Research map: The efficacy of targeted therapies in metastatic squamous cell carcinoma of the lung: a Turkish Oncology Group multicentre study
Back to the article
Papers in this map
Cancer statistics, 2022
· Rebecca L. Siegel · 2022 · 18359 citations · Cited by this paper
The impact of low-volume hydration on kidney function in low-dose cisplatin therapy for biliary tract cancer: a multicentre retrospective cohort study
· 2026 · Related
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
· Tony S.K. Mok · 2009 · 8328 citations · Cited by this paper
Pharmacokinetic/pharmacodynamic optimization of antimicrobial therapy in neutropenic sepsis: a comprehensive review
· 2026 · Related
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
· Rafael Rosell · 2012 · 5561 citations · Cited by this paper
Successful remdesivir treatment of coronavirus OC43 pneumonia in a lung transplant recipient
· 2025 · Related
Osimertinib in Untreated EGFR -Mutated Advanced Non–Small-Cell Lung Cancer
· Jean‐Charles Soria · 2017 · 5482 citations · Cited by this paper
A Phase 1 study of abemaciclib plus abiraterone in Japanese patients with metastatic castration-resistant prostate cancer
· 2025 · Related
The biology and management of non-small cell lung cancer
· Roy S. Herbst · 2018 · 5124 citations · Cited by this paper
A 1:1:1 propensity score matching design to account for center-specific antimicrobial treatment or prophylaxis in observational studies: the case of the POSACOVID study
· 2026 · Related
Comprehensive genomic characterization of squamous cell lung cancers
· Peter S. Hammerman · 2012 · 4082 citations · Cited by this paper
Striking effectiveness of siltuximab-based treatment in refractory idiopathic multicentric Castleman disease resembling IgG4-related disease
· 2025 · Related
Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer
· Luis G Paz-Ares · 2018 · 3711 citations · Cited by this paper
The role of gut microbiome in chemoresistance property development in colorectal cancer tissue and its novel therapeutic strategies
· 2026 · Related
Osimertinib or Platinum–Pemetrexed in EGFR T790M–Positive Lung Cancer
· Tony S.K. Mok · 2016 · 3397 citations · Cited by this paper
Influencing factors of acute severe to very severe peripheral neuropathy induced by albumin-bound paclitaxel
· 2025 · Related
First-Line Crizotinib versus Chemotherapy in ALK -Positive Lung Cancer
· Benjamin J. Solomon · 2014 · 3249 citations · Cited by this paper
Oritavancin as sequential therapy for vancomycin-resistant Enterococcus faecium prosthetic valve endocarditis: a case report
· 2026 · Related
Alectinib versus Crizotinib in Untreated ALK -Positive Non–Small-Cell Lung Cancer
· Solange Peters · 2017 · 2583 citations · Cited by this paper
Furmonertinib activity in NSCLC Harbouring EGFR L858R and ERBB2 S310F co-mutations: a case report with literature review
· 2025 · Related
Crizotinib in ROS1-Rearranged Non–Small-Cell Lung Cancer
· Alice Tsang Shaw · 2014 · 2014 citations · Cited by this paper
First-Line Lorlatinib or Crizotinib in Advanced ALK -Positive Lung Cancer
· Alice Tsang Shaw · 2020 · 1117 citations · Cited by this paper
The International Epidemiology of Lung Cancer: Latest Trends, Disparities, and Tumor Characteristics
· Ting‐Yuan David Cheng · 2016 · 621 citations · Cited by this paper
Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Harboring BRAF Mutations
· Antonio Marchetti · 2011 · 570 citations · Cited by this paper
Signaling pathways and targeted therapies in lung squamous cell carcinoma: mechanisms and clinical trials
· Zhenyi Niu · 2022 · 181 citations · Cited by this paper
A Platform for Rapid Detection of Multiple Oncogenic Mutations With Relevance to Targeted Therapy in Non–Small-Cell Lung Cancer
· Zengliu Su · 2011 · 176 citations · Cited by this paper
Lung cancer in never smokers: Change of a mindset in the molecular era
· Young Ju Lee · 2011 · 119 citations · Cited by this paper
EGFR-Mutated Squamous Cell Lung Cancer and Its Association With Outcomes
· Rui Jin · 2021 · 56 citations · Cited by this paper
Prevalence and clinical association of gene mutations through multiplex mutation testing in patients with NSCLC: results from the ETOP Lungscape Project
· Keith M. Kerr · 2017 · 50 citations · Cited by this paper
Efficacy of Targeted Inhibitors in Metastatic Lung Squamous Cell Carcinoma With EGFR or ALK Alterations
· Whitney E. Lewis · 2021 · 28 citations · Cited by this paper
The effect of EGFR‐TKIs on survival in advanced non‐small‐cell lung cancer with EGFR mutations: A real‐world study
· Xiaoqing Yu · 2022 · 11 citations · Cited by this paper
Source: OpenAlex (CC0)